LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Prosthetic Joint Infections Test Receives CE Marking

By LabMedica International staff writers
Posted on 05 Feb 2015
The first diagnostic test that can detect in patients' blood antibodies against several bacteria types frequently responsible for prosthetic infections, in particular Staphylococcus, the most often encountered type in such infections.

The new test has received Conformité Européenne (CE) marking, and provides qualitative information in a couple of hours for each targeted bacteria types, which enables caregivers, in association with the usual assessments, to accelerate and improve the care of patients who have prosthetic joint infections.

Image: On the left are the typical radiographic findings of infection with irregular bone destruction and periosteal reaction. In many cases however the infection is really low grade and difficult to establish (Photo courtesy of Radiological Society of the Netherlands).
Image: On the left are the typical radiographic findings of infection with irregular bone destruction and periosteal reaction. In many cases however the infection is really low grade and difficult to establish (Photo courtesy of Radiological Society of the Netherlands).

This BJI InoPlex test (Diaxonit; Paris France) requires 10 µl of serum taken by a simple blood draw and can be easily repeated. After adequate preparation, the test is carried out directly in the biology laboratory of the hospital with a standard Luminex instrument (Luminex; Austin, TX, USA). The test uses a combination of several recombinant protein antigens to test for anti-Staphylococcus immunoglobulin G (IgG for S. aureus and S. epidermidis). The BJI InoPlex kit contains various reagents necessary to perform the test, a 96-well filter plate, calibration CD-ROM containing specific calibration information for each batch and a user manual. The BJI InoPlex software is used to interpret the data and report a result per family of bacteria.

The performance of BJI InoPlex compared with microbiological results on intraoperative samples are respectively 82.2% for specificity and 75.9% for sensitivity, all types of targeted staphylococci included. Other bacteria targeted by BJI InoPlex are less frequent in the prevalence of prosthetic infections, and the incidence of proven intraoperative infections with these bacteria also ended up being limited in the study cohort. The high specificity of the test for two families of bacteria, Group B-Streptococcus and Propionibacterium acnes, preferentially orients towards the absence of an immune response against these types of bacteria, BJI InoPlex is being used in addition to other tests performed.

Related Links:
Diaxonit
Luminex



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Prefilled Tubes
Prefilled 5.0ml Tubes
Clinical Informatics Platform
CLARION™

Latest Microbiology News

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection
05 Feb 2015  |   Microbiology

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps
05 Feb 2015  |   Microbiology

Proteomic Workflow Maps Microbial and Host Responses in Intestinal Inflammation
05 Feb 2015  |   Microbiology